George Anastassov
Director/Board Member at INCANNEX HEALTHCARE INC.
Net worth: 2 M $ as of 2024-04-29
George Anastassov active positions
Companies | Position | Start | End |
---|---|---|---|
INCANNEX HEALTHCARE INC. | Director/Board Member | 2022-06-27 | - |
Stichting Sanammad | Director/Board Member | 2008-12-31 | - |
Founder | 2008-12-31 | - | |
Corporate Officer/Principal | 2008-12-31 | - | |
Sanammad Pharmaceuticals BV | Director/Board Member | 2013-12-31 | - |
Founder | 2013-12-31 | - | |
Corporate Officer/Principal | 2013-12-31 | - | |
CanChew License Co.
CanChew License Co. Miscellaneous Commercial ServicesCommercial Services CanChew License Co. provides licensing services. The company is headquartered in Reno, NV. | Director/Board Member | - | - |
President | - | - | |
Corporate Secretary | - | - | |
Treasurer | - | - |
Career history of George Anastassov
Former positions of George Anastassov
Companies | Position | Start | End |
---|---|---|---|
RYAH GROUP, INC. | Director/Board Member | 2021-04-20 | 2022-12-05 |
APIRX Pharmaceuticals USA LLC
APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Founder | 2016-12-31 | 2021-12-31 |
Corporate Officer/Principal | 2016-12-31 | 2021-12-31 | |
AXIM BIOTECHNOLOGIES, INC. | Chief Executive Officer | 2014-04-30 | 2019-01-01 |
Chairman | 2014-04-30 | 2020-05-05 | |
Director of Finance/CFO | 2014-04-30 | - | |
Founder | 2014-04-30 | 2020-05-05 | |
President | 2014-04-30 | 2019-01-01 | |
Corporate Secretary | 2014-04-30 | - | |
CanChew Biotechnologies LLC
CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Director/Board Member | 2011-12-31 | - |
Chief Executive Officer | 2013-07-29 | - | |
Founder | 2011-12-31 | - |
Training of George Anastassov
University of Tennessee | Undergraduate Degree |
NYU College of Dentistry | Doctorate Degree |
Statistics
International
United States | 8 |
Netherlands | 4 |
Operational
Director/Board Member | 6 |
Founder | 5 |
Corporate Officer/Principal | 3 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
INCANNEX HEALTHCARE INC. | Health Technology |
AXIM BIOTECHNOLOGIES, INC. | Health Technology |
RYAH GROUP, INC. | Technology Services |
Private companies | 5 |
---|---|
CanChew Biotechnologies LLC
CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Health Technology |
Stichting Sanammad | Miscellaneous |
Sanammad Pharmaceuticals BV | |
CanChew License Co.
CanChew License Co. Miscellaneous Commercial ServicesCommercial Services CanChew License Co. provides licensing services. The company is headquartered in Reno, NV. | Commercial Services |
APIRX Pharmaceuticals USA LLC
APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Health Technology |
- Stock Market
- Insiders
- George Anastassov
- Experience